Interferons and viruses: Signaling for supremacy

Immunologic Research

Volumn 35, Issue 1-2, 2006, Pages 27-39

  Galligan, C L ^b   Murooka, T T ^b   Rahbar, R ^b   Baig, E ^b   Majchrzak Kita, B ^b   Fish, E N ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE

Author keywords

Antiviral; Interferon; Signal transduction

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CELL SURFACE RECEPTOR; INTERFERON;

CELLULAR IMMUNITY; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INHIBITION;

EID: 33749592160     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:35:1:27     Document Type: Review

References (67)

1. Isaacs A, Lindenmann J: Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957;147:258-267.
2. Brierley MM, Fish EN: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res 2002;22:835-845.
3. Chen J, Baig E, Fish EN: Diversity and relatedness among the type I interferons. J Interferon Cytokine Res 2004;24:687-698.
4. Deonarain R, Chan, DCM, Platanias LC, Fish, EN: Interferon-α/ β-receptor interactions: a complex story unfolding. Curr Pharm Des 2002;8:2131-2137.
5. Uze G, Lutfalla G, Gresser I ; Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 1990;60: 225-234.
6. Lutfalla G, Holland SJ, Cinato E, et al: Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J 1995;14:5100-5108.
7. Domanski P, Witte M, Kellum M, et al: Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J Biol Chem 1995;270:21606-21611.
8. Ghislain J, Lingwood CA, Fish E.N; Evidence for glycosphingolipid modification of the type 1 interferon receptor. J Immunol 1994;153:3655-3663.
9. Platanias LC: Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005;5: 375-386.
10. Brierley MM, Fish EN: Stats: multifaceted regulators of transcription. J Interferon Cytokine Res 2005; 25: 733-744.
11. Ghislain JJ, Fish EN: Application of genomic DNA affinity chromatography identifies multiple interferon-alpha-regulated Stat2 complexes. J Biol Chem 1996; 271:12408-12413.
12. Li X, Leung S, Qureshi S, Darnell JE Jr, Stark GR: Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferonalpha. J Biol Chem 1996;271:5790-5794.
13. Ghislain JJ, Wong T, Nguyen M, Fish EN: The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. J Interferon Cytokine Res 2001;21:379-388.
14. Brierley MM, Fish EN: Functional relevance of the conserved DNA-binding domain of STAT2. J Biol Chem 2005;280:13029-13036.
15. Ahmad S, Alsayed YM, Druker BJ, Platanias LC: The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J Biol Chem 1997;272:29991-29994.
16. Fish EN, Uddin S, Korkmaz M, Majchrzak B, Druker BJ, Platanias LC: Activation of a CrkL-stat5 signaling complex by type I interferons. J Biol Chem 1999;274:571-573.
17. Uddin S, Lekmine F, Sassano A, Rui H, Fish EN, Platanias LC: Role of Stat5 in type I interferon-signaling and transcriptional regulation. Biochem Biophys Res Commun 2003;308:325-330.
18. Uddin S, Majchrzak B, Woodson J, et al: Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem 1999;274:30127-30131.
19. Uddin S, Lekmine F, Sharma N, et al: The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alphadependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem 2000;275:27634-27640.
20. Platanias LC, Sweet ME: Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J Biol Chem 1994;269: 3143-3146.
21. Li Y, Batra S, Sassano A, et al: Activation of mitogen-actiovated protein kinas kinase (MKK)3 and MKK6 by type I interferons. J Biol Chem 2005;280:10001-10010.
22. Li Y, Sassano A, Majchrzak B, et al: Role of p38α Map kinase in type I interferon signaling. J Biol Chem 2004;279:970-979.
23. Clayton AL, Mahadevan LC: MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett 2003;546:51-58.
24. Burfoot MS, Rogers NC, Watling D, et al: Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem 1997;272:24183-24190.
25. Platanias LC, Uddin S, Yetter A, Sun XJ, White MF: The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem 1996;271:278-282.
26. Uddin S, Fish EN, Sher D, et al: The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-alpha receptors. Blood 1997;90:2574-2582.
27. Uddin S, Majchrzak B,Wang PC, et al: Interferon-dependent activation of the serine kinase PI-3′ kinase requires engagement of the IRS pathway but not the Stat pathway. Biochem Biophys Res Commun 2000;270:158-162.
28. Lekmine F, Uddin S, Sassano A, et al: Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J Biol Chem 2003;278:27772-27780.
29. Uddin S, Sassano A, Deb DK, et al: Protein kinase Cdelta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 2002;277:14408-14416.
30. Prejean C, Sarma T, Kurnasov O, et al: Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors. J Immunol 2001;167:453-459.
31. Deonarain R, Alcami A, Alexiou M, Dallman MJ, Gewert DR, Porter AC: Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J Virol 2000;74:3404-3409.
32. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN: Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 2004;110:3540-3543.
33. Hwang SY, Hertzog PJ, Holland KA, et al: A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci USA 1995;92:11284-11288.
34. Durbin JE, Fernandez-Sesma A, Lee CK, et al; Type I IFN modulates innate and specific antiviral immunity. J Immunol 2000;164:4220-4228.
35. Bray M: The role of the type I interferon response in the resistance of mice to filovirus infection. J Gen Virol 2001;82:1365-1373.
36. Wessely R, Klingel K, Knowlton KU, Kandolf R: Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation 2001;103(5):756-761.
37. Durbin JE, Hackenmiller R, Simon MC, Levy DE: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996;84:443-450.
38. Vancott JL, McNeal MM, Choi AH,Ward RL: The role of interferons in rotavirus infections and protection. J Interferon Cytokine Res 2003;23:163-170.
39. Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E: Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 2005;175:3946-3954.
40. Hashimoto K, Durbin JE, Zhou W, et al: Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J Allergy Clin Immunol 2005;116:550-557.
41. Park C, Li S, Cha E, Schindler C: Immune response in Stat2 knockout mice. Immunity 2000;13:795-804.
42. Strobl B, Bubic I, Bruns U, et al: Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J Immunol 2005;175:4000-4008.
43. Heim A, Stille-Seigener M, Pring-Akerblom P, et al: Recombinant Interferons beta and gamma have a higher antiviral activity than interferon-alpha in coxsackievirus B3-infected carrier state cultures of human myocardial fibroblasts. J Interferon Cytokine Res 1996;16:283-287.
44. Teige I, Treschow A, Teige A, et al: IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol 2003;170:4776-4784.
45. Alton K, Stabinsky Y, Richards R, et al: Production, characterization and biological effects of recombinant DNA derived humans IFN-α and IFN-γ analogs; in De Maeyer, E, Schellekens, H (eds); The biology of the IFN system. Elsevier-Science, 1983, pp. 119-128.
46. Blatt LM, Davis JM, Klein SB, Taylor MW: The biologic activity and molecular characterization of a novel synthetic IFN-alpha species, consensus IFN. J Interferon Res 1996;16:489-499.
47. Loutfy MR, Blatt LM, Siminovitch KA, et al: Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrom. J Am Med Assoc 2003;290:3222-3228.
48. Zorzitto J, Galligan CL, Ueng JJM, Fish EN: Characterization of the antiviral effects of interferon-α against a SARS-like coronavirus infection in vitro. Cell Res 2006;16;220-229.
49. Basler CF, Garcia-Sastre A:Viruses and the type I interferon antiviral system: induction and evasion. Int Rev Immunol 2002;21:305-337.
50. Katze MG, He Y, Gale M Jr: Viruses and interferon: a fight for supremacy. Nature Rev Immunol 2002;2: 675-687.
51. Spiegel M, Pichlmair A, Martinez-Sobrido L, et al: Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 2005;79:2079-2086.
52. Mahalingam S, Clark K, Matthaei KI, Foster PS: Antiviral potential of chemokines. Bioessays 2001;23:428-435.
53. McFadden G: Poxvirus tropism. Nat Rev Microbiol 2005;3:201-213.
54. Seet BT, Johnston JB, Brunetti CR, et al: Poxviruses and immune evasion. Annu Rev Immunol 2003;21: 377-423.
55. Sodhi A, Montaner S, Gutkind JS: Viral hijacking of G-protein-coupled- receptor signalling networks. Nat Rev Mol Cell Biol 2004;5:998-1012.
56. Couty JP, Gershengorn MC: G-protein-coupled receptors encoded by human herpesviruses. Trends Pharmacol Sci 2005;26:405-411.
57. Nicholas J: Human gammaherpesvirus cytokines and chemokine receptors. J Interferon Cytokine Res 2005; 25:373-383.
58. Lalani AS, Masters J, Zeng W, et al: Use of chemokine receptors by poxviruses. Science 1999;286:1968-1971.
59. Masters J, Hinek AA, Uddin S, et al: Poxvirus infection rapidly activates tyrosine kinase signal transduction. J Biol Chem 2001;276:48371-48375.
60. Wong M, Fish EN: RANTES and MIP-1alpha activate stats in T cells. J Biol Chem 1998;273:309-314.
61. Wong M, Uddin S, Majchrzak B, et al: Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J Biol Chem 2001;276: 11427-11431.
62. Rahbar R, Hinek AA, Murooka TT, et al: Vaccinia virus activaction of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication. J Virol 2006;80:7245-7249.
63. Wang F, Ma Y, Barrett JW, et al: Disruption of Erkdependent type I interferon induction breaks the myxoma virus species barrier. Nat Immunol 2004;5: 1266-1274.
64. Johnston JB, Nazarian SH, Natale R, McFadden G: Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses. Virol 2005;332:235-248.
65. Colamonici OR, Domanski P, Sweitzer SM, Larner A, Buller RM: Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem 1995;270: 15974-15978.
66. Symons JA, Alcami A, Smith GL: Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 1995;81: 551-560.
67. Chang HW, Watson JC, Jacobs BL: The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 1992;89:4825-4829.